Background

The Drug Enforcement Administration has announced its intent to issue an order temporarily including the following synthetic opioid into schedule I of the Controlled Substances Act.

N,N-diethyl-2-(2-(4isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine (commonly known as isotonitazene), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever their existence is possible

Once issued, the temporary scheduling order will impose the regulatory controls under the CSA on the importation, exportation, manufacture, distribution, reverse distribution, possession, research and conduct of instructional activities, and chemical analysis of this substance as well as the administrative, civil, and criminal penalties that apply to persons who fail to comply with such controls or otherwise violate the CSA with respect to these substances. This order will be effective no earlier than July 20 and remain in effect for two years, with a possible extension of one year.

Copyright © 2020 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.

ST&R: International Trade Law & Policy

Since 1977, we have set the standard for international trade lawyers and consultants, providing comprehensive and effective customs, import and export services to clients worldwide.

View Our Services 

Close

Cookie Consent

We use cookies on our website. By continuing to use our website, you agree to the Privacy Policy and Terms of Use.